1. Home
  2. ATYR vs OTH Comparison

ATYR vs OTH Comparison

Compare ATYR & OTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.84

Market Cap

83.3M

Sector

Health Care

ML Signal

HOLD

OTH

Off The Hook YS Inc.

N/A

Current Price

$2.39

Market Cap

67.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ATYR
OTH
Founded
2005
2012
Country
United States
United States
Employees
59
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
67.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATYR
OTH
Price
$0.84
$2.39
Analyst Decision
Hold
Analyst Count
8
0
Target Price
$4.20
N/A
AVG Volume (30 Days)
1.4M
23.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9,628.95
N/A
Revenue Next Year
$156.94
N/A
P/E Ratio
N/A
$600.18
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$1.95
52 Week High
$7.29
$3.75

Technical Indicators

Market Signals
Indicator
ATYR
OTH
Relative Strength Index (RSI) 43.50 45.64
Support Level $0.82 $2.03
Resistance Level $0.85 $2.72
Average True Range (ATR) 0.07 0.21
MACD -0.02 -0.01
Stochastic Oscillator 7.78 36.36

Price Performance

Historical Comparison
ATYR
OTH

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

About OTH Off The Hook YS Inc.

Off The Hook YS Inc operates as a nationwide leader in the yacht and boat dealership industry, offering a comprehensive suite of services that spans the entire boat value chain. The company operates as two segments: Boat Sales and Azure Funding. Boat Sales includes Specializing in the buying, selling, and wholesaling of yachts and boats, having a boat dealership created to run Yellow Fin sales in Miami; and Azure Funding includes a recreational loan broker and lender providing financing solutions for individuals, dealerships, and brokerages.

Share on Social Networks: